SCM
LEGN icon

Sterling Capital Management’s Legend Biotech LEGN Stock Holding History

Sterling Capital Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-21,482
Closed -$389K – 3358
2026
Q1 		$389K Sell
21,482
-12,793
-37% -$244K 0.01% 888
2025
Q4 		$745K Buy
34,275
+33
+0.1% +$945 0.01% 749
2025
Q3 		$1.12M Sell
34,242
-41,105
-55% -$1.52M 0.02% 598
2025
Q2 		$2.67M Buy
75,347
+7
+0% +$227 0.04% 306
2025
Q1 		$2.56M Sell
75,340
-8,531
-10% -$306K 0.04% 297
2024
Q4 		$2.73M Buy
83,871
+4,443
+6% +$184K 0.04% 319
2024
Q3 		$3.87M Buy
+79,428
New +$4.23M 0.05% 263

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Sterling Capital Management's LEGN Position: Q2 2026 in Review

Sterling Capital Management sold out of Legend Biotech (LEGN) in Q2 2026, closing a stake of 21,482 shares — an estimated $389K sold.

Sterling Capital Management first reported a position in LEGN in Q3 2024 and held it in 7 quarters. The position peaked at $3.87M in Q3 2024. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Sterling Capital Management reported no remaining Legend Biotech position as of Q2 2026 after selling out during the quarter.
  • Sterling Capital Management sold 21,482 Legend Biotech shares in Q2 2026, an estimated $389K.
  • Sterling Capital Management first reported a position in Legend Biotech in Q3 2024 and held it in 7 quarters.
  • Sterling Capital Management's Legend Biotech position peaked at $3.87M in Q3 2024.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.